More News

15 May 2018

TapImmune and Marker Therapeutics Announce Entry into Merger Agreement, Creating a Transformational Immuno-Oncology Platform

15 May 2018

Kite Announces New Worldwide Facilities and Expanded Collaboration With National Cancer Institute to Support Cell Therapy Pipeline

15 May 2018

Zymeworks and Daiichi Sankyo Expand Immuno-Oncology Collaboration Focused on Bispecific Antibodies

14 May 2018

Lilly to Acquire AurKa Pharma

14 May 2018

Medigene significantly expands TCR alliance with bluebird bio in cancer immunotherapy

14 May 2018

Catalent Biologics and Valerius Biopharma to Collaborate on Manufacture of Specialty Biosimilars

10 May 2018

Lilly Announces Agreement To Acquire ARMO BioSciences

10 May 2018

FORMA Therapeutics and the University of Oxford Announce Multi-Year Collaboration to Advance the Development of Deubiquitinating Enzyme (DUB) Inhibitors for the Treatment of Neurodegenerative Diseases

10 May 2018

Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan

9 May 2018

Lodo Therapeutics Corporation Forms Multi-Target Strategic Collaboration with Genentech

9 May 2018

Provention Bio Announces Agreements with MacroGenics for Two Clinical-Stage Assets for the Treatment of Autoimmune Disorders

8 May 2018

Atara Biotherapeutics Expands T-Cell Immunotherapy Collaboration to Advance Next-Generation CAR T Technologies in Oncology, Autoimmune and Other Diseases

8 May 2018

Proposed Acquisition of Shire plc by Takeda

7 May 2018

Aptose Exercises Early Option for CG-806 License From CrystalGenomics

7 May 2018

LipimetiX Development Announces Sub-License of Apo E Mimetic Peptide Platform to Anji Pharma, China

4 May 2018

Sarepta Therapeutics Announces Partnership with Myonexus Therapeutics for the Advancement of Multiple Gene Therapy Programs Aimed at Treating Distinct Forms of Limb-Girdle Muscular Dystrophies

4 May 2018

Exelixis and Invenra Enter Into Collaboration to Discover and Develop Novel Biologics to Treat Cancer

4 May 2018

Moderna and Merck Expand mRNA Cancer Vaccines Collaboration

3 May 2018

Third Rock Ventures Launches Casma Therapeutics with $58.5 Million Investment to Harness the Cellular Process of Autophagy to Develop Breakthrough Therapies

3 May 2018

Ferring Signs Global Agreement to Commercialise Novel Gene Therapy for Bladder Cancer Patients

2 May 2018

Bactevo Enters Drug Discovery Agreement with Boehringer Ingelheim

2 May 2018

Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimens

2 May 2018

Merck KGaA, Darmstadt, Germany to Develop Abituzumab in Metastatic Colorectal Cancer with SFJ Pharmaceuticals Group

1 May 2018

Biogen and Neurimmune Announce Option Exercise for Alzheimer’s Disease Investigational Treatment Aducanumab

30 April 2018

4DMT and ROCHE Expand Ophthalmology Partnership to Develop and Commercialize Multiple AAV Gene Therapy Products

30 April 2018

WuXi Biologics to Invest €325 Million to Build Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland

25 April 2018

Boehringer Ingelheim R&D Pushes to Transcend Disease Boundaries

25 April 2018

Entasis Therapeutics and Zai Lab Announce Exclusive License Agreement in Asia-Pacific and Global Strategic Development Collaboration for ETX2514

24 April 2018

Zymeworks and Celgene Expand Bispecific Antibody Collaboration

23 April 2018

CBT Pharmaceuticals and CrystalGenomics Announce Partnership for Co-development of Global Immuno-Oncology Therapy

News Channels

Newsletter

La Merie Biologics

La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.

Newsletter La Merie Biologics

Newsletter

New Product Alert

La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.

Newsletter new product alert

Featured reports

Claudin 18.2-Targeted Immunotherapy: a landscape analysis of stakeholders, drug modalities, pipeline and business opportunities from an industry perspective

CAR-M Industry Landscape Analysis: Chimeric Antigen Receptor-Macrophage (CAR-M) Stakeholders, Technologies, Pipeline, Partnering and Financing

Fibroblast Activation Protein (FAP) Targeted Therapy & Companion Diagnostic Pipeline Review

Report Package: “Drug the Undruggable” Technologies

Mesothelin-Targeted Immunotherapy Pipeline Review

Degrader-Antibody Conjugates 2024: A Landscape Analysis of Stakeholders, Technologies, Pipeline and Partnering from an Industry Perspective

Her3-Targeted Immunotherapy Pipeline Review

PD-L1 x 4-1BB (CD137) Bispecific Antibody Pipeline Review

EpCAM-Targeted Antibodies Pipeline Review

Tocilizumab (Actemra/RoActemra) Biosimilar Antibody Pipeline Review